- Home
- CSTL vs IGR Comparison
CSTL vs IGR Comparison
Compare CSTL & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- IGR
- Stock Information
- Founded
- CSTL 2007
- IGR 2004
- Country
- CSTL United States
- IGR United States
- Employees
- CSTL N/A
- IGR N/A
- Industry
- CSTL Medical Specialities
- IGR Finance Companies
- Sector
- CSTL Health Care
- IGR Finance
- Exchange
- CSTL Nasdaq
- IGR Nasdaq
- Market Cap
- CSTL 848.1M
- IGR 721.1M
- IPO Year
- CSTL 2019
- IGR N/A
- Fundamental
- Price
- CSTL $25.75
- IGR $5.22
- Analyst Decision
- CSTL Strong Buy
- IGR
- Analyst Count
- CSTL 6
- IGR 0
- Target Price
- CSTL $40.33
- IGR N/A
- AVG Volume (30 Days)
- CSTL 358.8K
- IGR 747.7K
- Earning Date
- CSTL 02-27-2025
- IGR 01-01-0001
- Dividend Yield
- CSTL N/A
- IGR 13.93%
- EPS Growth
- CSTL N/A
- IGR N/A
- EPS
- CSTL 0.21
- IGR N/A
- Revenue
- CSTL $311,878,000.00
- IGR N/A
- Revenue This Year
- CSTL $51.99
- IGR N/A
- Revenue Next Year
- CSTL N/A
- IGR N/A
- P/E Ratio
- CSTL $122.41
- IGR N/A
- Revenue Growth
- CSTL 62.43
- IGR N/A
- 52 Week Low
- CSTL $16.97
- IGR $3.88
- 52 Week High
- CSTL $35.84
- IGR $5.70
- Technical
- Relative Strength Index (RSI)
- CSTL 37.34
- IGR 49.29
- Support Level
- CSTL $26.65
- IGR $5.23
- Resistance Level
- CSTL $28.48
- IGR $5.36
- Average True Range (ATR)
- CSTL 1.12
- IGR 0.07
- MACD
- CSTL -0.17
- IGR -0.00
- Stochastic Oscillator
- CSTL 0.94
- IGR 46.30
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
About IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.